Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9901
Medallion Financial
MFIN
$274M
| $423K | ﹤0.01% |
+47,709
| New | +$412K |
|
9902
TRX Gold Corp
TRX
$377M
| $423K | ﹤0.01% |
830,052
-92,079
| -10% | -$49.7K |
|
9903
PUT
Health Catalyst
HCAT
$120M
| $422K | ﹤0.01% |
7,600
+600
| +9% | +$32K |
|
9904
PUT
nVent Electric
NVT
$24B
| $422K | ﹤0.01% |
+13,500
| New | +$416K |
|
|
OPRA
9905
PUT
Opera Ltd
OPRA
$1.74B
| $422K | ﹤0.01% |
+41,200
| New | +$437K |
|
9906
CALL
Radware
RDWR
$1.2B
| $422K | ﹤0.01% |
13,700
-16,300
| -54% | -$470K |
|
9907
CALL
Siebert Financial
SIEB
$90M
| $422K | ﹤0.01% |
87,700
+67,400
| +332% | +$279K |
|
9908
PUT
ProShares UltraShort Dow 30
DXD
$43.9M
| $421K | ﹤0.01% |
8,980
-160
| -2% | -$7.76K |
|
9909
CALL
iShares MSCI Singapore ETF
EWS
$1.23B
| $421K | ﹤0.01% |
18,100
-13,700
| -43% | -$323K |
|
9910
CALL
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.64B
| $421K | ﹤0.01% |
+14,000
| New | +$413K |
|
9911
CALL
ProShares Short High Yield
SJB
$45.5M
| $421K | ﹤0.01% |
23,500
-17,800
| -43% | -$324K |
|
9912
Vishay Precision Group
VPG
$833M
| $421K | ﹤0.01% |
+12,379
| New | +$411K |
|
|
BWAC
9913
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
| $421K | ﹤0.01% |
42,148
-86,109
| -67% | -$860K |
|
|
EQD
9914
DELISTED
Equity Distribution Acquisition Corp.
EQD
| $421K | ﹤0.01% |
42,798
+15,561
| +57% | +$154K |
|
9915
PUT
ENI
E
$76.1B
| $420K | ﹤0.01% |
17,200
-6,500
| -27% | -$162K |
|
|
IMDX
9916
CALL
Insight Molecular Diagnostics
IMDX
$135M
| $420K | ﹤0.01% |
3,655
+820
| +29% | +$80.1K |
|
9917
PUT
Usana Health Sciences
USNA
$259M
| $420K | ﹤0.01% |
4,100
-3,000
| -42% | -$301K |
|
9918
Voyager Therapeutics
VYGR
$218M
| $420K | ﹤0.01% |
101,597
+55,301
| +119% | +$251K |
|
|
LEAP
9919
PUT
DELISTED
Ribbit LEAP, Ltd.
LEAP
| $420K | ﹤0.01% |
+39,300
| New | +$424K |
|
|
SLT
9920
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
| $420K | ﹤0.01% |
9,888
+324
| +3% | +$13.3K |
|
9921
PUT
Intellicheck
IDN
$57.6M
| $419K | ﹤0.01% |
50,000
-6,100
| -11% | -$50K |
|
9922
Imunon
IMNN
$8.98M
| $419K | ﹤0.01% |
1,686
+646
| +62% | +$153K |
|
9923
Opus Small Cap Value ETF
OSCV
$685M
| $419K | ﹤0.01% |
12,851
+4,589
| +56% | +$151K |
|
|
PRPH
9924
PUT
DELISTED
ProPhase Labs
PRPH
| $419K | ﹤0.01% |
6,750
+1,290
| +24% | +$72.5K |
|
9925
Pricesmart
PSMT
$5.23B
| $419K | ﹤0.01% |
4,608
+36
| +0.8% | +$3.21K |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.